Clinical Trials in a Molecular World

Dawid Schellingerhout; Juri Gelovani

doi:10.1016/j.nic.2006.08.003

Clinical Trials in a Molecular World

Dawid Schellingerhout, Juri Gelovani

Image Guided Cancer Therapy Research Program

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

The problems described are the problems of a field in its youth or infancy, and is in symmetry with tremendous opportunities. Molecular imaging is destined to be the fulcrum of future clinical trials involving molecular therapies. This future is inevitable, but can it be hastened by improved insight into the complexities faced by the molecular imaging community as it strives to move these technologies forward to the clinic.

Original language	English (US)
Pages (from-to)	681-694
Number of pages	14
Journal	Neuroimaging Clinics of North America
Volume	16
Issue number	4
DOIs	https://doi.org/10.1016/j.nic.2006.08.003
State	Published - Nov 2006

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Clinical Neurology

Access to Document

10.1016/j.nic.2006.08.003

Cite this

@article{956c56b5a9ad4f24b4f792968134390e,

title = "Clinical Trials in a Molecular World",

abstract = "The problems described are the problems of a field in its youth or infancy, and is in symmetry with tremendous opportunities. Molecular imaging is destined to be the fulcrum of future clinical trials involving molecular therapies. This future is inevitable, but can it be hastened by improved insight into the complexities faced by the molecular imaging community as it strives to move these technologies forward to the clinic.",

author = "Dawid Schellingerhout and Juri Gelovani",

year = "2006",

month = nov,

doi = "10.1016/j.nic.2006.08.003",

language = "English (US)",

volume = "16",

pages = "681--694",

journal = "Neuroimaging Clinics of North America",

issn = "1052-5149",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Clinical Trials in a Molecular World

AU - Schellingerhout, Dawid

AU - Gelovani, Juri

PY - 2006/11

Y1 - 2006/11

N2 - The problems described are the problems of a field in its youth or infancy, and is in symmetry with tremendous opportunities. Molecular imaging is destined to be the fulcrum of future clinical trials involving molecular therapies. This future is inevitable, but can it be hastened by improved insight into the complexities faced by the molecular imaging community as it strives to move these technologies forward to the clinic.

AB - The problems described are the problems of a field in its youth or infancy, and is in symmetry with tremendous opportunities. Molecular imaging is destined to be the fulcrum of future clinical trials involving molecular therapies. This future is inevitable, but can it be hastened by improved insight into the complexities faced by the molecular imaging community as it strives to move these technologies forward to the clinic.

UR - http://www.scopus.com/inward/record.url?scp=37849188975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849188975&partnerID=8YFLogxK

U2 - 10.1016/j.nic.2006.08.003

DO - 10.1016/j.nic.2006.08.003

M3 - Review article

C2 - 17148026

AN - SCOPUS:37849188975

SN - 1052-5149

VL - 16

SP - 681

EP - 694

JO - Neuroimaging Clinics of North America

JF - Neuroimaging Clinics of North America

IS - 4

ER -

Clinical Trials in a Molecular World

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this